Th1 dominance in HAM/TSP and the optico-spinal form of multiple sclerosis versus Th2 dominance in mite antigen-specific IgE myelitis

Journal of the Neurological Sciences

Volumn 172, Issue 1, 2000, Pages 17-24

  Horiuchi, Izumi ^a   Kawano, Yuji ^a   Yamasaki, Kenji ^a   Minohara, Motozumi ^a   Furue, Masutaka ^b   Taniwaki, Takayuki ^a   Miyazaki, Toshiyasu ^c   Kira, Jun ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c Otsuka Tokyo Assay Laboratories   (Japan)

Author keywords

HAM TSP; IgE; Multiple sclerosis; Myelitis; Th1 Th2 balance

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 4;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE STATUS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELITIS; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADULT; ANIMALS; CYTOKINES; FLOW CYTOMETRY; HTLV-I INFECTIONS; HUMANS; IMMUNOGLOBULIN E; MULTIPLE SCLEROSIS; MYELITIS; PARAPARESIS, TROPICAL SPASTIC; TH1 CELLS; TH2 CELLS;

EID: 0033989669     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00232-4     Document Type: Article

References (29)

1. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today. 17:1996;138-146.
2. Stenius B., Wide L., Seymour W.M., Holford-Strevens V Pepys J. Clinical significance of specific IgE to common allergens. I. Relationship of specific IgE against Dermatophagoides spp. and grass pollen to skin and nasal tests and history. Clin Allergy. 1:1971;37-55.
3. Rudikoff D., Lebwohl M. Atopic dermatitis. Lancet. 351:1998;1715-1721.
4. Allanore Y., Hilliquin P., Coste J., Renoux M., Menkès C.J. Decreased prevalence of atopy in rheumatoid arthritis. Lancet. 351:1998;497.
5. Shirakawa T., Enomoto T., Shimazu S., Hopkin J.M. The inverse association between tuberculin responses and atopic disorders. Science. 275:1997;77-79.
6. Panitch H.S., Hirsh R.L., Schindler J., Johnson K.P. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology. 37:1987;1097-1102.
7. Beck J., Rondot P., Catinot L., Falcoff E., Kirchiner H., Wietzerbin J. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand. 78:1988;318-323.
8. Lu C.-Z., Jensen M.A., Arnason B.G.W. Interferon γ- and interleukin-4-secreting cells in multiple sclerosis. J Neuroimmunol. 46:1993;123-128.
9. Navikas V., Link H. Review: cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res. 45:1996;322-333.
10. Crucian B., Dunne P., Friedman H., Ragsdale R., Pross S., Widen R. Detection of altered T helper 1 and helper 2 cytokine production by peripheral blood mononuclear cells in patients with multiple sclerosis utilizing intracellular cytokine detection by flow cytometry and surface marker analysis. Clin Diagn Lab Immunol. 3:1996;411-416.
11. Shibasaki H., McDonald W.I., Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J Neurol Sci. 49:1981;253-271.
12. Ito H., Yamasaki K., Kawano Y., Horiuchi I., Yun C., Nishimura Y., Kira J. HLA-DP-associated susceptibility to the optico-spinal form of multiple sclerosis in the Japanese. Tissue Antigens. 52:1998;179-182.
13. Kira J., Kanai T., Nishimura Y., Yamasaki K., Matsushita S., Kawano Y., Hasuo K., Tobimatsu S., Kobayashi T. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol. 40:1996;569-574.
14. Picker L.J., Singh M.K., Zdraveski Z., Treer J.R., Waldrop S.L., Bergstresser P.R., Maino V.C. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood. 86:1995;1408-1419.
15. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis. Ann Neurol. 13:1983;227-231.
16. Osame M., Matsumoto M., Usuku K., Izumo S., Ijichi N., Amitani H., Tara M., Igata A. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemia-like cells. Ann Neurol. 21:1987;117-122.
17. Kira J., Kawano Y., Yamasaki K., Tobimatsu S. Acute myelitis with hyperIgEaemia and mite antigen-specific IgE: atopic myelitis. J Neurol Neurosurg Psychiatry. 64:1998;676-679.
18. Kira J., Yamasaki K., Kawano Y., Kobayashi T. Acute myelitis associated with hyperIgEemia and atopic dermatitis. J Neurol Sci. 148:1997;199-203.
19. Kira J., Kawano Y., Horiuchi I., Yamada T., Imayama S., Furue M., Yamasaki K. Clinical, immunological and M.R.I. features of myelitis with atopic dermatitis (atopic myelitis). J Neurol Sci. 162:1999;56-61.
20. Olerup O., Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens. 38:1991;1-15.
21. Austrup F., Vestweber D., Borges E., Löhning M., Bräuer R., Herz U., Renz H., Hallmann R., Scheffold A., Radbruch A., Hamann A. P- and E-selectin mediate recruitment of T-helper-1 but not T- helper-2 cells into inflamed tissues. Nature. 385:1997;81-83.
22. Hayashi J., Kishihara Y., Yoshimura E., Furusyo N., Yamaji K., Kawakami Y., Murakami H., Kashiwagi S. Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan. Am J Trop Med Hyg. 56:1997;71-75.
23. Scholz C., Hafler D.A., Höllsberg P. Downregulation of IL-10 secretion and enhanced antigen-presenting abilities following HTLV I infection of T cells. J Neurosci Res. 45:1996;786-794.
24. Sagawa K., Mochizuki M., Katagiri K., Tsuboi I., Sugita S., Mukaida N., Itoh K. In vitro effects of immunosuppresive agents on cytokine production by HTLV-I-infected T cell clones derived from the ocular fluid of patients with HTLV-I uveitis. Microbiol Immunol. 40:1996;373-379.
25. Kuroda Y., Matsui M. Cerebrospinal fluid interferon-gamma is increased in HTLV-1-associated myelopathy. J Neuroimmunol. 42:1993;223-226.
26. Rothe M.J., Grant-Kels A. Atopic dermatitis. J Am Acad Dermatol. 35:1996;1-13.
27. Merétey K., Jakab Á., Szilassy K., Medgyesi G.A. IgE levels in normal human sera and IgG preparations. Haematologia. 22:1989;151-159.
28. Orren A., Dowdle E.B. The effects of sex and age on serum IgE concentrations in three ethnic groups. Int Arch Allergy Appl Immunol. 48:1975;824-835.
29. Nakagawa M., Izumo S., Ijichi S., Kubota H., Arimura K., Kawabata M., Osame M. HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol. 1:1995;50-61.